Companies Related to "Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer" [Most Relevant Company Matches] - Page: 2 RSS

16:17 EST 16th February 2019 | BioPortfolio

Here are the most relevant search results for "Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer" found in our extensive corporate database of over 50,000 company records.

Showing "Radiation Therapy Mitomycin Either Fluorouracil Cisplatin Treating Patients" Companies 26–50 of 4,900+



Emmerex is an early stage bio-pharmaceutical company. It aims to bring to market an anti-cancer therapy. The Emmerex therapy arose as a result of several years' biological research. It has already been proven to be safe in patients. The Emmerex therapy utilises the patients' own innate ability to fight cancer. It cuts off nutrient source of the cancer and attacks the tumours directly. The Emmerex ...

Xoft Inc.

Xoft, founded in 1998, develops Electronic Brachytherapy (eBx) systems based upon miniaturized X-ray tube technology for the practice of radiation oncology in virtually any clinical setting, eliminating the need for heavily shielded environments. Xoft provides a "point of care model" that is patient centric and accessible to a broader spectrum of patients and their physicians. The Axxent treat...

North Shore Hematology Oncology Associates

Welcome to North Shore Hematology Oncology Associates, PC. For over twenty years, NSHOA has been a community-based private practice providing premium healthcare for our patients using the latest treatment techniques. We are always on the cutting edge of technology and medicine, while ensuring that our patients are treated with dignity and respect. Although we generally only care for adults, we do ...

VisCardia Inc

VisCardia based in Portland, OR is developing a novel implantable device therapy for treating heart failure, a condition that afflicts 10 million patients in the U.S. and Europe. To learn more about VisCardia, visit:

VisCardia Inc.

VisCardia, based in Portland, OR, is developing a novel implantable device therapy for treating heart failure, a condition that afflicts 10 million patients in the U.S. and Europe. To learn more about VisCardia, visit:

Radiation Therapy Oncology Group

Radiation Therapy Services Holdings, Inc.

Parnell Pharmaceuticals

Parnell Pharmaceuticals is the first company dedicated to the research and development of new and innovative products to restore and maintain mucosal integrity, thereby improving the quality of life of those patients, who for diverse reasons are "mucocompromised", and therefore at increased risk for secondary infections. The majority of these patients are defined as immunocompromised for various r...

Provision Center for Proton Therapy

Opening in early 2014, the Provision Center for Proton Therapy will be the first of its kind in Tennessee and only the second in the Southeast. Proton therapy, the most advanced form of radiotherapy in the world, uses a single beam of high-energy protons to treat various forms of cancer. Different from conventional radiation therapy — in which beam en...

The Center for Radiation Therapy of Beverly Hills

Oncolytics Biotech Inc.

Oncolytics Biotech Inc. was formed in 1998 to develop its proprietary product, REOLYSIN®, as a potential therapeutic for a wide variety of human cancers. Oncolytics has completed five clinical trials with REOLYSIN® in Canada and the U.K. and is currently conducting four Phase I or Phase I/II REOLYSIN® trials in the U.K. and the U.S. The company also has permission to commence a Phase II combina...

Corporate Communications, CEL-SCI Corporation

CEL-SCI Corporation (AMEX: CVM), a biotechnology company, was formed in 1983. CEL-SCI is involved in the research and development of drugs and vaccines for the treatment of cancer and infectious diseases. The Company’s core capabilities include drug discovery, research, development and manufacturing of complex biological substances.Recurrence of cancer is the greatest fear for the cancer patient...

Calypso Medical Technologies, Inc.

Calypso Medical Technologies, Inc. is a Seattle-based, privately held medical device company. The Company’s proprietary tumor localization system utilizes miniaturized implanted devices (Beacon electromagnetic transponders) to continuously, accurately and objectively track the location of tumors for improved accuracy and management of radiation therap...

ProCure Treatment Centers, Inc.

ProCure Treatment Centers, Inc. is a privately held healthcare company dedicated to improving the lives of patients with cancer by increasing access to proton therapy. The company was founded in 2005 in Bloomington, Ind., and is the first to develop a network of proton therapy centers in cities across the United States. The ProCure Proton Therapy Center in...


Vasomedical Inc. provides superior medical products and services that address unmet clinical needs in the management of patients with heart disease. The company’s core technology, EECP® therapy, provides healthcare professionals a non-invasive therapy for patients suffering from cardiovascular diseases. EECP therapy helps patients and their families lead active and productive lives. With ov...

Brooklyn ImmunoTherapeutics LLC

Brooklyn ImmunoTherapeutics (formerly IRX Therapeutics) is focused on exploring the role that cytokine-based therapy can have in treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies.

Tennessee Cancer Patient Coalition

The Tennessee Cancer Patient Coalition’s mission is to serve as an advocate for cancer patients and their caregivers. The Coalition believes cancer patients should have the opportunity to make informed decisions about their care and have equal access to the most advanced treatment methods available. Proton Therapy is the most advanced form of radiatio...

Scandidos AB

Scandidos AB provides the quality assurance (QA) technology that ensures radiation doses in advanced radiation therapy are delivered to the patient in the quantity and manner that was intended. The company’s measurement systems and software are designed to meet QA requirements and provide validation of the new cancer radiation treatments being impleme...

OncoWell, LLC

OncoWell, LLC, headquartered in New York, NY, provides complementary products and resources to patients undergoing cancer treatment. The company’s first offering, OncoWellCE, is a concentrated enzyme product to support patient wellness while undergoing chemotherapy or radiation therapy. OncoWell, LLC was founded in 2012 by James Nicholls, Peter Jenkin...

Texas Center for Proton Therapy

Texas Center for Proton Therapy is the North Texas region’s first proton therapy center. The center features latest-generation technology, including pencil-beam scanning and image-guided proton therapy, providing precise radiation treatment with the opportunity to reduce side effects. Opening in late 2015, the facility will provide advanced cancer tre...

Hygieia, Inc.

Hygieia, Inc. is an emerging diabetes health care company developing new ways to improve the effectiveness of therapy while reducing the cost of diabetes care. Hygieia’s first product is a handheld Diabetes Insulin Guidance System (DIGS™) designed to improve insulin therapy effectiveness for patients. DIGS works in a way that makes it a feasible ...

ViewRay, Inc.

ViewRay, Inc., of Cleveland, Ohio, is a privately held medical device company developing advanced radiation therapy technology for the treatment of cancer. Using MRI-guided radiotherapy, the ViewRay system is intended to provide continuous soft-tissue imaging during treatment. The system is designed so that clinicians -- for the first time -- will be able to see the actual radiation dose being del...

Oncora Medical, Inc.

Oncora Medical, Inc., a privately held software company in Philadelphia, PA, has developed a powerful predictive analytics platform for oncology, capable of analyzing diverse healthcare data and applying advanced machine learning techniques to produce clinical insights. Currently, Oncora is improving the radiation therapy experience with software to...

Pharmacyclics Incorporated

Pharmacyclics, Inc. is a pharmaceutical company developing energy-potentiating drugs to improve radiation therapy andchemotherapy of cancer, and to enable or improve the photodynamic therapy of certain cancers, atherosclerotic cardiovascular disease and retinal diseases. The Company's products are ring-shaped small molecules, called "texaphyrins,"which are patented agents derived from Pharmacyclic...

Mevion Medical Systems, Inc.

Mevion Medical Systems, Inc. is a radiation therapy company dedicated to advancing the treatment of cancer. As the pioneering developer of proton therapy systems, Mevion provides innovative, safe and effective solutions by transforming advances in medical technology and science into practical clinical reality.

More From BioPortfolio on "Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer"

Quick Search


Corporate Database Quicklinks